Overview

Gender

male

Simon has 30 years’ experience in both Biotech and Big Pharma and was recently Chief Business Officer at Creabilis Ltd, responsible for commercial and business activities and culminated a series of deals and financing with negotiating the sale of Creabilis to Sienna Bio-pharmaceuticals Inc in the US in December 2016.

With Sienna he supported the subsequent listing of Sienna on NASDAQ in July 2017 and the creation of a new 500 Mio USD dermatology company.

In his Big Pharma career, he has held senior global commercial roles at both Novartis as Head of Strategic Marketing for Biologics and AstraZeneca in Switzerland, Sweden and the UK, taking several products through Phase III and launch and defining development strategies for many early products across a wide range of therapy areas. Earlier he held significant R&D roles in Clinical Development, Development Management and Medicinal Chemistry.

He holds a PhD in Organic Chemistry from Southampton University and an MA in Chemistry from the University of Oxford in the UK.